Pregnancy associated atypical hemolytic uremic syndrome presenting with preeclampsia with HELLP syndrome and following treatment with Eculizumab
2022

Pregnancy Associated Atypical Hemolytic Uremic Syndrome Treated with Eculizumab

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Gunawan Fery, Mangler Mandy, Sanders Cindy, Leonardo Trisha Ardine, Cindy Yosefina

Primary Institution: Department of Obstetric and Gynecology, Hospital Werner Forßmann, Eberswalde, Germany

Conclusion

Eculizumab treatment significantly improved the patient's condition after a diagnosis of pregnancy-associated atypical hemolytic uremic syndrome.

Supporting Evidence

  • The patient was diagnosed with HELLP syndrome but later revealed to have p-aHUS.
  • Eculizumab was administered after the diagnosis of p-aHUS.
  • Clinical and laboratory signs improved after treatment with Eculizumab.
  • The patient was discharged after 20 days with significantly improved condition.

Takeaway

A pregnant woman with a serious condition called p-aHUS was treated with a medicine called Eculizumab, which helped her get better after a difficult delivery.

Methodology

The patient was treated with Eculizumab after being diagnosed with p-aHUS following a Caesarean section.

Limitations

More studies are required to determine a standardized treatment regimen for p-aHUS.

Participant Demographics

32-year-old Caucasian woman, 38 weeks pregnant.

Digital Object Identifier (DOI)

10.1515/crpm-2022-0016

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication